tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mark Landy, 6 are a BUY (85.71%), 1 are a HOLD (14.29%).
Analyst Mark Landy, carries an average stock price target met ratio of 83.33% that have a potential upside of 34.07% achieved within 1487 days. Previously, Mark Landy worked at NORTHLAND CAPITAL MARKETS, SUMMER STREET.
Mark Landy’s has documented 15 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CNMD, CONMED at 22-Jul-2015.
Analyst best performing recommendations are on CNMD (CONMED).
The best stock recommendation documented was for CNMD (CONMED) at 2/14/2014. The price target of $53 was fulfilled within 515 days with a profit of $11.8 (28.64%) receiving and performance score of 0.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 01-May-2026
$46
$-0.32 (-0.69%)
$39
2 months 5 days ago
(30-Jul-2026)
2/2 (100%)
$-0.98 (-2.09%)
62
Hold Since 30-Jul-2026
$45
$-1.32 (-2.85%)
$39
2 months 5 days ago
(30-Jul-2026)
17/25 (68%)
$-1.98 (-4.21%)
200
Hold Since 03-Mar-2022
$40
$-6.32 (-13.64%)
$52
3 months 6 days ago
(29-Jun-2026)
1/5 (20%)
$5.59 (16.25%)
14
Hold Since 25-Apr-2024
$42
$6.05 (16.83%)
$47
8 months 6 days ago
(29-Jan-2026)
3/6 (50%)
$4.69 (12.57%)
13
Hold Since 29-Jan-2026
$61
8 months 6 days ago
(29-Jan-2026)
26/43 (60.47%)
$6.44 (11.80%)
351
